1 00:00:02,520 --> 00:00:08,720 Speaker 1: Bloomberg Audio Studios, Podcasts, radio News, The. 2 00:00:08,720 --> 00:00:12,560 Speaker 2: Stock Movers Report, your roundup of companies making moves in 3 00:00:12,600 --> 00:00:15,880 Speaker 2: the stock market, harnessing the power of Bloomberg data. 4 00:00:16,440 --> 00:00:17,880 Speaker 3: Let's look at some of the starts on the move 5 00:00:17,960 --> 00:00:20,560 Speaker 3: today here in Europe. I'm Caroline Hepgar with Tom McKenzie, 6 00:00:20,560 --> 00:00:24,040 Speaker 3: and we're joined by Bloomberg reporter Chloe Malay. Chloe, good morning, 7 00:00:24,120 --> 00:00:27,880 Speaker 3: Good morning. Now let's think about what is happening in 8 00:00:27,920 --> 00:00:31,000 Speaker 3: Europe and particularly for Ryan Matta, one of the defense 9 00:00:31,080 --> 00:00:34,600 Speaker 3: stocks which is falling. This is always quite a difficult 10 00:00:34,600 --> 00:00:38,839 Speaker 3: market correlation. The idea of peace in Ukraine actually is 11 00:00:38,880 --> 00:00:41,279 Speaker 3: a setback for the defense name. 12 00:00:41,440 --> 00:00:45,000 Speaker 1: Yeah, absolutely very classic case of peace talks progressing and 13 00:00:45,080 --> 00:00:48,440 Speaker 1: defense shares falling, and we have seen that for Ryan Mattel, 14 00:00:48,520 --> 00:00:52,280 Speaker 1: but also other names like Hensalton and Leonardo this morning. 15 00:00:52,320 --> 00:00:55,080 Speaker 1: So we are entering the second day of talks between 16 00:00:55,160 --> 00:00:58,400 Speaker 1: Ukraine and the US in Berlin, and the big focus 17 00:00:58,440 --> 00:01:02,360 Speaker 1: of the negotiations at the moment is around security are guarantees. 18 00:01:02,400 --> 00:01:05,959 Speaker 1: So Zelenski has hinted that Ukraine could actually back away 19 00:01:06,240 --> 00:01:09,320 Speaker 1: from its long term goal of joining NATO and instead 20 00:01:09,360 --> 00:01:13,560 Speaker 1: accept bilateral security guarantees from the US, Europe and other 21 00:01:13,640 --> 00:01:17,520 Speaker 1: states including Japan. So this actually signals quite good progress 22 00:01:17,560 --> 00:01:20,119 Speaker 1: on those peace talks, and as a result, we're seeing 23 00:01:20,160 --> 00:01:24,000 Speaker 1: that weakness today in those defense as shares. So this 24 00:01:24,120 --> 00:01:26,440 Speaker 1: is actually even despite the fact that even if we 25 00:01:26,480 --> 00:01:29,679 Speaker 1: do have peace in Ukraine doesn't necessarily mean that the 26 00:01:29,720 --> 00:01:33,000 Speaker 1: countries will stop spending on defense. But there always seems 27 00:01:33,040 --> 00:01:36,000 Speaker 1: to be that correlation in the market between news of 28 00:01:36,080 --> 00:01:37,880 Speaker 1: peace and defense stocks prices. 29 00:01:38,720 --> 00:01:42,400 Speaker 3: Automaker stocks in focus as well this morning, the focus 30 00:01:42,400 --> 00:01:44,920 Speaker 3: on climate change rules and maybe some adjustments from the 31 00:01:44,920 --> 00:01:45,760 Speaker 3: EU yees. 32 00:01:45,800 --> 00:01:47,800 Speaker 1: So the EU is preparing to soften some of those 33 00:01:47,880 --> 00:01:51,480 Speaker 1: rules around combuntion engine cars. So currently the rules are 34 00:01:51,800 --> 00:01:54,600 Speaker 1: that the new combustion engine vehicles will actually be banned 35 00:01:54,800 --> 00:01:57,280 Speaker 1: from twenty thirty five, but what the EU is considering 36 00:01:57,320 --> 00:02:01,160 Speaker 1: now is either extend that deadline for five years or 37 00:02:01,200 --> 00:02:03,280 Speaker 1: take the band filly off the table. So that would 38 00:02:03,520 --> 00:02:07,160 Speaker 1: essentially allow those carmakers in Europe to transition to emission 39 00:02:07,160 --> 00:02:09,800 Speaker 1: free cars over a longer period of time, and that 40 00:02:09,840 --> 00:02:12,600 Speaker 1: could be a relief for those companies. You know, European 41 00:02:12,840 --> 00:02:16,320 Speaker 1: car companies have struggled to remain competitive and the removal 42 00:02:16,360 --> 00:02:19,360 Speaker 1: of maybe some of that regulatory burden could help with that, 43 00:02:19,520 --> 00:02:21,959 Speaker 1: So that would be good breathing room. But then the 44 00:02:22,080 --> 00:02:25,079 Speaker 1: risk is that it could actually slow development of some 45 00:02:25,160 --> 00:02:28,240 Speaker 1: kind of new green technologies, slow also the reaching of 46 00:02:28,280 --> 00:02:31,600 Speaker 1: some climate targets, and that could potentially widen the gap 47 00:02:31,639 --> 00:02:34,680 Speaker 1: between what you know, US companies like Tesla can do 48 00:02:34,720 --> 00:02:38,919 Speaker 1: in terms of technology versus what Mercedes Stellant's BMW etc. 49 00:02:39,480 --> 00:02:42,320 Speaker 1: Could Have to offer here in Europe. So that has 50 00:02:42,320 --> 00:02:44,320 Speaker 1: to be taken into account as well. So there's some 51 00:02:44,400 --> 00:02:48,079 Speaker 1: caveat to that, and that explains some gains in Stellantis 52 00:02:48,080 --> 00:02:51,959 Speaker 1: this morning, but quite modest, actually modest gains in those shares. Hm. 53 00:02:52,520 --> 00:02:59,040 Speaker 3: Okay. Let's also think about the pharmaceuticals sector. Our Jenks 54 00:03:00,200 --> 00:03:03,440 Speaker 3: has had an issue with one of its important drug trials. 55 00:03:03,560 --> 00:03:06,000 Speaker 1: Yeah. So RJX is a biotech company based in the 56 00:03:06,080 --> 00:03:08,960 Speaker 1: Netherlands and it essentially has one flagship drug that I 57 00:03:08,960 --> 00:03:11,320 Speaker 1: will not attempt to pronounce, but one flagship drug and 58 00:03:11,360 --> 00:03:14,480 Speaker 1: that is used for a variety of applications for autoimmune diseases. 59 00:03:14,520 --> 00:03:17,560 Speaker 1: And the shares have actually rallied quite impressively over the 60 00:03:17,639 --> 00:03:20,359 Speaker 1: last a few months because it's been able to get 61 00:03:20,440 --> 00:03:22,800 Speaker 1: a lot of wins in terms of successful trials, but 62 00:03:23,040 --> 00:03:25,800 Speaker 1: it has just encountered a big a setback, so it 63 00:03:25,800 --> 00:03:29,280 Speaker 1: has it had to discontinue studies that were checking if 64 00:03:29,280 --> 00:03:32,680 Speaker 1: it could use that flagship drug for a thyroage eye disease. 65 00:03:32,720 --> 00:03:35,080 Speaker 1: And so this rules out now a population of about 66 00:03:35,080 --> 00:03:37,880 Speaker 1: one hundred thousand in the US, and that puts pressure 67 00:03:38,120 --> 00:03:41,160 Speaker 1: on these sales ambition for twenty thirty and also puts 68 00:03:41,200 --> 00:03:43,440 Speaker 1: a little bit more scrutiny on the results of other 69 00:03:43,920 --> 00:03:47,560 Speaker 1: trials or other catalysts that are coming next year in 70 00:03:47,880 --> 00:03:50,800 Speaker 1: kind of better use perhaps for RGENX. And multiple analysts 71 00:03:50,840 --> 00:03:54,160 Speaker 1: have said that the share price weakness today is actually 72 00:03:54,160 --> 00:03:56,880 Speaker 1: a buying opportunity, so they say that the fundamentals do 73 00:03:57,000 --> 00:04:00,120 Speaker 1: remain strong. It's kind of a temporary setback where we've 74 00:04:00,120 --> 00:04:01,960 Speaker 1: seen a lot of weakness in the Chez VALSI. 75 00:04:02,000 --> 00:04:07,680 Speaker 2: Next this morning the Stockmover's Report from Bloomberg Radio. Check 76 00:04:07,720 --> 00:04:10,080 Speaker 2: back with us throughout the day for the latest roundup 77 00:04:10,120 --> 00:04:13,040 Speaker 2: of companies making news on Wall Street and for the 78 00:04:13,120 --> 00:04:17,560 Speaker 2: latest market moving headlines. Listen to Bloomberg Radio Live, catch 79 00:04:17,640 --> 00:04:21,120 Speaker 2: us on YouTube, Bloomberg dot com, and on Applecarplay and 80 00:04:21,120 --> 00:04:23,520 Speaker 2: Android Auto with the Bloomberg Business app